Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Hold Ninety One (N91) by Numis
- Buy Centrica (CNA) by Goldman Sachs
- Buy HSBC Holdings (HSBA) by Edward Sheldon in The Motley Fool
- Buy Tesco (TSCO) by Edward Sheldon in The Motley Fool
- Buy Unilever (ULVR) by Edward Sheldon in The Motley Fool
- Watch Glencore (GLEN) by Jon Smith in The Motley Fool
- Hold Burberry Group (BRBY) by Kepler Cheuvreux
- Watch Reckitt Benckiser Group (RKT) by Charlie Carman in The Motley Fool
- Buy Kingspan Group (0KGP) by Kepler Cheuvreux
- Buy Moneysupermarket.com Group (MONY) by Peel Hunt
- Buy Flutter Entertainment (DI) (FLTR) by Deutsche Bank
- Buy M&G (MNG) by Simon Watkins in The Motley Fool
- Buy Alphawave IP Group (AWE) by Deutsche Bank
- Hold AstraZeneca (AZN) by Deutsche Bank
- Neutral Learning Technologies Group (LTG) by Goldman Sachs
- Sell Dr. Martens (DOCS) by Goldman Sachs
- Overweight Oxford Instruments (OXIG) by JP Morgan
- Neutral Auction Technology Group (ATG) by JP Morgan
- Buy Sage Group (SGE) by Citi
- Buy Savills (SVS) by HSBC
ReNeuron Group (RENE) Share Price
Health Care Sector
NOTE: This is based on 3 open tips for ReNeuron Group (RENE)
| Latest Bid : 3.25p | Latest Ask : 3.50p |
| High Today : 3.50p | Low Today : 3.27p |
| This Years High : 11.12p | This Years Low : 3.27p |
| Volume : 177,374 | MKT Cap : £1.93M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
24/01/2018 – Stock Consolidation 100.000:1.000
ReNeuron Group (RENE) Overview
ReNeuron is a UK based Proprietary Stem Cell based Exosome Technologies company. Its primary objective is the development of novel stem cell based technologies targeting areas of significant unmet or poorly met medical need.ReNeuron Group (RENE) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Nigel Somerville | Premium Only | 2023-11-09 08:40:00 09/11/2023 | 35.10% |
| Risky Buy | Peter Stephens | Premium Only | 2016-12-05 14:11:43 05/12/2016 | -60.62% |
| Buy | N+1 Singer | Premium Only | 2014-12-10 11:23:25 10/12/2014 | 78.57% |
ReNeuron Group (RENE) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 3.25p | Latest Ask : 3.50p |
| High Today : 3.50p | Low Today : 3.27p |
| This Years High : 11.12p | This Years Low : 3.27p |
| Volume : 177,374 | MKT Cap : £1.93M |
ReNeuron Group Overview
ReNeuron is a UK based Proprietary Stem Cell based Exosome Technologies company. Its primary objective is the development of novel stem cell based technologies targeting areas of significant unmet or poorly met medical need.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest ReNeuron Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Nigel Somerville | Premium Only | 2023-11-09 08:40:00 09/11/2023 | 35.10% |
| Risky Buy | Peter Stephens | Premium Only | 2016-12-05 14:11:43 05/12/2016 | -60.62% |
| Buy | N+1 Singer | Premium Only | 2014-12-10 11:23:25 10/12/2014 | 78.57% |
Stock Splits and Consolidations
24/01/2018 – Stock Consolidation 100.000:1.000